Shanshan Li | Molecular Biology | Excellence in Research Award

Dr. Shanshan Li | Molecular Biology | Excellence in Research Award

Assistant Researcher | Zhejiang University | China

Dr. Shanshan Li is a dedicated researcher specializing in the chemistry, processing, and bioactivity of bee-derived products, with a strong emphasis on propolis, royal jelly, and protein–polyphenol systems. Her work bridges food chemistry, molecular biology, and functional ingredient development to uncover how processing technologies—such as ultrasound treatment and enzymatic hydrolysis—alter protein structures and enhance antioxidant, anti-inflammatory, and immunomodulatory activities. She has significantly advanced the understanding of protein–polyphenol interactions and their role in improving the functional properties of natural compounds. Dr. Li employs advanced analytical approaches, including proteomics, transcriptomics, and bioinformatics, to investigate molecular mechanisms and cellular pathways influenced by bee product components. Her research also includes comparative studies of milk fat globule membrane proteins across animal species, contributing to broader innovations in food science and bioactive ingredient development. With 998 citations across 943 documents, 50 publications, and an h-index of 21, Dr. Li has established a strong scientific presence. Her contributions support the development of health-promoting ingredients and the translation of natural bioactives into functional foods.

Profiles: Scopus

Featured Publications

Ultrasound-induced modifications in structure, antioxidant activity and functionality of whey protein isolate–propolis polyphenol conjugates. Food Chemistry.

Integrated transcriptomics and network pharmacology reveal the mechanism of poplar-type propolis on the mouse mastitis model. Nutrients.

Structural and antioxidative properties of royal jelly protein by partial enzymatic hydrolysis. Food Science and Human Wellness.

Royal jelly proteins and their derived peptides: Preparation, properties, and biological activities. Journal of Agricultural and Food Chemistry.

Milk fat globule membrane proteins among buffalo breeds via TMT proteomics. Food Research International.

 

María Victoria Zelaya Huerta | Molecular Pathology | Women Researcher Award

Dr. Maria Victoria Zelaya Huerta | Molecular Pathology | Women Researcher Award 

Dr. María Victoria Zelaya Huerta | University Hospital of Navarra | Spain

Dr. María Victoria Zelaya Huerta has established herself as a highly respected figure in pathology and neuropathology, with her work widely cited and recognized internationally. These metrics demonstrate the significance and influence of her contributions, underscoring how her studies have informed subsequent investigations and advanced medical knowledge. Beyond bibliometric achievements, she has been consistently acknowledged for her academic excellence and dedication to both clinical and translational research. Her recognition includes institutional distinctions for her pioneering work in breast cancer sentinel lymph node studies and molecular insights into Alzheimer’s disease. Dr. Zelaya has also been invited to present at numerous national and international pathology congresses, further highlighting the value of her research within the scientific community. Her international training and collaborations in Argentina, Spain, Taiwan, the Netherlands, and the United States have earned her fellowships and professional commendations, strengthening her global profile. With 47 scientific documents, over 992 total citations from 816 articles, and an h-index of 19, her research has had a strong impact across the fields of neuropathology, neurodegenerative diseases, and cancer pathology. As a tutor of residents, she continues to inspire and mentor the next generation of pathologists, solidifying her legacy as both a researcher and educator.

Profile: Scopus | ORCID

Featured Publications

Gelpi, E., Höftberger, R., Graus, F., & Duyckaerts, C. Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: Updated neuropathological research criteria of the disease-related tauopathy. Acta Neuropathologica.

Profiling TREM2 expression in amyotrophic lateral sclerosis. Acta Neuropathologica.

Clinical, histopathologic and genetic features of rhabdoid meningiomas. International Journal of Molecular Sciences.

Pathological features in paediatric patients with TK2 deficiency. International Journal of Molecular Sciences.

Gul Cirkin | Molecular Medicine | Best Researcher Award

Dr. Gul Cirkin | Molecular Medicine | Best Researcher Award 

Pediatric Gastroenterologist | Tepecik Training and Research Hospital, Izmir | Turkey 

Dr. Gül Çirkin is a highly accomplished Pediatric Gastroenterologist currently serving at Tepecik Training and Research Hospital in İzmir, Turkey. Over the course of her career, she has built a strong foundation in pediatrics and subspecialized in pediatric gastroenterology, with a focus on improving child health through clinical excellence, research, and academic contributions. Her educational path began with a Doctor of Medicine degree from Dicle University Faculty of Medicine, followed by a Pediatrics Residency at Çukurova University Faculty of Medicine. She later pursued a Pediatric Gastroenterology Fellowship at Dokuz Eylül University Faculty of Medicine, where she deepened her expertise in pediatric hepatology, endoscopy, and nutritional disorders. Professionally, she has served as a research assistant, pediatrician, and pediatric gastroenterologist in leading hospitals across Turkey, gaining extensive clinical and academic experience. Her research interests include celiac disease, pediatric liver diseases, childhood obesity, nutritional disorders, and pediatric endoscopy. She has published in respected journals and actively presented her work at international conferences, including the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the European Society for Clinical Nutrition and Metabolism. Her contributions to research and clinical care have earned her recognition as a promising leader in pediatric gastroenterology and hepatology.

Profile: Scopus

Featured Publications

Trends in Pediatrics. (2021). Evaluation of success rate of exogenous obesity management. Trends in Pediatrics.

Trends in Pediatrics. (2022). Study of liver effect in children with celiac disease. Trends in Pediatrics.

Endoscopy. (2023). Botryoid rhabdomyosarcoma or parasites: Transnasal choledoscopy as a diagnostic tool. Endoscopy.

Medicine (Baltimore). (2024). Evaluation of endoscopic retrograde cholangiopancreatography in Turkish children. Medicine (Baltimore).

Turkish Journal of Gastroenterology. (2024). Clinical and molecular analysis in patients with Peutz–Jeghers syndrome. Turkish Journal of Gastroenterology.

Turkish Journal of Pediatrics. (2024). Evaluation of functional gastrointestinal disorders in children with autism spectrum disorder. Turkish Journal of Pediatrics.

Constantin-Ioan Busuioc | Molecular Pathology | Best Researcher Award

Dr. Constantin-Ioan Busuioc | Molecular Pathology | Best Researcher Award

Pathologist, at Saint Mary Clinical Hospital, Romania.

Dr. Constantin-Ioan Busuioc is a distinguished Romanian pathologist with a strong background in both clinical and research domains. Born on January 29, 1985, he has devoted his career to exploring the intricate dynamics of pathology, with special focus on oncologic and hematologic conditions. He is currently affiliated with Saint Mary Clinical Hospital in Bucharest, where he plays a pivotal role in surgical specimen analysis and histopathological diagnostics. Over the years, Dr. Busuioc has amassed considerable experience across institutions in Romania, Switzerland, and Italy, enriching his expertise in diagnostic pathology. His research contributions, particularly in colorectal cancer and immunohistochemistry, have gained recognition in high-impact journals. Known for his clinical precision and academic depth, he bridges the gap between research and real-world pathology. Dr. Busuioc is fluent in English and French, and actively participates in both national and international medical networks. 🧬💉🧪

Professional Profile

Scopus

🎓 Education

Dr. Constantin-Ioan Busuioc’s educational journey exemplifies dedication to academic excellence in medicine. He completed his Medical Doctor (M.D.) degree at the University of Medicine and Pharmacy “Iuliu Haţieganu” in Cluj-Napoca, Romania (2005–2011) 🩺. Subsequently, he pursued a Ph.D. at the same institution from 2015 to 2022, delving into molecular and immunohistochemical aspects of malignancies, particularly colorectal adenocarcinoma. His rigorous research training culminated in several significant publications and conference presentations. In 2021, he obtained a Certificate in Health Services Management from the National School of Public Health, Management and Training, enhancing his administrative and healthcare policy knowledge 📊. Additionally, he undertook a fellowship in Hematopathology at the prestigious European Institute of Oncology in Milan, Italy, under Prof. Dr. Stefano A. Pileri. This diverse academic path has equipped him with a well-rounded perspective, blending clinical pathology, biomedical research, and health systems management. 📚🧠

🏥 Experience

With over a decade of professional experience, Dr. Busuioc has held key pathology roles across several European institutions. His current role at Saint Mary Clinical Hospital (since 2023) involves high-stakes diagnostics, intraoperative evaluations, and necropsies. From 2021 to 2023, he served at the National Institute of Infectious Diseases “Prof. Dr. Matei Balș”, specializing in infectious pathology, autopsies, and immunohistochemistry. 🧫 Earlier roles include long-term service at Oncoteam Diagnostic and previous tenure at Synevo, where he managed complex diagnostic cases involving general and hematopathology. Internationally, he worked as Chef de Clinique at Valais Hospital in Switzerland (2018–2019) and completed an intensive fellowship at the European Institute of Oncology, Italy. His foundational years were spent as a resident at Cluj-Napoca County Hospital, with rotations at specialized hospitals including the Oncology Institute and Gastroenterology Institute. His vast experience shapes his precision in diagnosis and depth in pathology. 🧬🦠

🧠 Research Interests

Dr. Busuioc’s research interests lie at the intersection of molecular oncology, immunohistochemistry, and epithelial-mesenchymal transition (EMT) in gastrointestinal malignancies, particularly colorectal and esophageal cancers. He is also intrigued by gene expression profiling, diagnostic biomarkers, and tumor microenvironment interactions. 🧬 His studies often explore the role of EMT markers like Vimentin and E-cadherin in predicting tumor progression. Utilizing bioinformatics tools, he analyzes molecular pathways and gene signatures such as MMP3 and TESC, aiming to enhance early detection and personalized treatment approaches. He has contributed significantly to the understanding of PD-L1 expression, particularly in esophageal carcinoma, and its immunological implications. Additionally, he has co-authored studies on rare case presentations such as Kikuchi-Fujimoto disease and lymphomas in gynecological tissues. His collaborative approach and interdisciplinary mindset make his research impactful and translational. 🔍🧫

🏆 Awards

Dr. Constantin-Ioan Busuioc has earned recognition for his commitment to excellence in pathology and oncology research. One of the highlights of his academic career is being part of the UEFISCDI-awarded article published in Cancers (Basel), which offered a comprehensive review of MAPK pathways as therapeutic targets in cancer. 🏅 His insightful contributions to colorectal cancer pathology and bioinformatics analysis have garnered attention in Romanian medical circles and abroad. His consistent publication in high-impact journals reflects a commendable academic rigor. He has also been nominated for multiple academic awards through Romanian and European research forums. His interdisciplinary case studies, particularly in complex co-morbidities, showcase his versatility as both a clinician and a researcher. These recognitions not only validate his scientific acumen but also reinforce his status as a dedicated and innovative medical professional. 🌟📖

📚Top Noted Publications

Dr. Busuioc has co-authored 12+ peer-reviewed articles in reputable international journals, reflecting his impactful work in pathology and molecular oncology:

  1. Aberrant Immunohistochemical Expression in Colorectal Adenocarcinoma
    Chirurgia (Bucur), 2022

    • Focus: Aberrant IHC patterns in colorectal cancer

    • Citations: 5

    • Notes: Highlights novel expression markers potentially linked to prognosis and therapy responsiveness.

  2. MMP3 & TESC in Colon Adenocarcinoma
    BioMedInformatics, 2022

    • Focus: Role of MMP3 and TESC genes in colon cancer progression using computational biology tools

    • Citations: 2

  3. EMT Gene Signature & Prognosis in Colon Adenocarcinoma
    Journal of Personalized Medicine, 2021

    • Focus: EMT-related gene expression linked to prognosis and patient stratification

    • Citations: 10

    • Impact: Widely referenced in personalized therapy literature.

  4. PD-L1 Expression in Esophageal Carcinomas
    Chirurgia (Bucur), 2022

    • Focus: PD-L1 immunostaining in esophageal cancer subtypes

    • Notes: Adds data to the ongoing debate on immunotherapy eligibility.

  5. MAPK Pathways Review: Biological Mechanisms & Therapeutic Targets in Oncology
    Cancers (Basel), 2019

    • Focus: Comprehensive review of MAPK signaling in cancer

    • Citations: 100+

    • Recognition: Award-winning article, highly cited in targeted therapy discussions.

  6. Multidisciplinary Team in Rectal Cancer Management: Integration & Outcomes
    Clujul Med, 2017

    • Focus: Clinical coordination in colorectal cancer treatment

    • Notes: Addresses practical framework for collaborative cancer care.

🩺 Internal Medicine, Autoimmunity & Rare Conditions

  1. Case of Acute Polyarthritis with Severe Comorbidity
    Internal Medicine, 2021

    • Focus: Complex internal medicine case with overlapping rheumatological and systemic features

  2. Sarcoidosis Associated with Solid Pseudopapillary Tumor: A Diagnostic Rarity
    Romanian Journal of Internal Medicine, 2022

    • Focus: Uncommon tumor presentation in a patient with sarcoidosis

  3. Episcleritis in Granulomatosis with Polyangiitis: A Diagnostic Challenge
    Romanian Journal of Ophthalmology, 2021

    • Focus: Ocular manifestation of a systemic vasculitis

  4. Kikuchi-Fujimoto Disease Mimicking Systemic Lupus Erythematosus
    Romanian Journal of Rhinology, 2022

    • Focus: Autoimmune overlap and diagnostic pitfalls

  5. Primary Gynecological Lymphomas: A Behavioural Case Perspective
    Annals of Behavioural Science, 2018

    • Focus: Behavioral and clinical aspects of gynecological lymphoma diagnosis and management

Conclusion

Dr. Constantin-Ioan Busuioc is a strong candidate for a Best Researcher Award, especially in the field of oncopathology, molecular diagnostics, and histopathology. His blend of clinical practice, interdisciplinary research, and international experience makes him highly competitive. With enhanced visibility in research leadership roles and international scholarly forums, his profile would be further elevated to a global best researcher standard.